Our Head of Integrated Therapeutics and CNS, Dr. Stephen Mitchell, our Business Development Manager, Janette Dalay Robertson and our Senior Research Scientist in CNS, Jewel Ahmed will be there to engage with attendees, share insights and explore new collaborations driving innovation in Parkinson’s disease drug discovery and development.
If you’re attending, don’t hesitate to reach out, they’ll be delighted to connect and discuss how
Pharmidex’s integrated expertise can help move your research from concept to clinic.

#Pharmidex #ParkinsonsDisease #DrugDiscovery #Neuroscience#CNS #PharmaInnovation #Collaboration #BMCS2025






